SCHEMBL6923069

SCHEMBL6923069

CCC1(C)CCn2c(nc3cc(CCc4ccccn4)ccc3c2=O)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 2/20 0.38
NSD2 O96028 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
POLB P06746 2/20 0.35
MAPK1 P28482 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
ACHE P22303 2/20 0.34
ADORA2B P29275 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
PKM P14618 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
USP2 O75604 1/20 0.33
CYP1A2 P05177 1/20 0.33
BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6922880 0.80 GRM2 (0.42) GRM2NPC1RAB9ANSD2TDP1
SCHEMBL6922693 0.76 GRM2 (0.41) GRM2NPC1RAB9ANSD2TDP1
SCHEMBL14239848 0.75 NPC1 (0.41) GRM2NPC1RAB9ANSD2TDP1
SCHEMBL14239067 0.72 METAP2 (0.40) NPC1RAB9ANSD2TDP1
SCHEMBL12059030 0.70 NPC1 (0.42) NPC1RAB9ANSD2TDP1ALDH1A1
SCHEMBL14239843 0.69 POLB (0.43) NPC1RAB9ANSD2TDP1POLB
SCHEMBL14239367 0.69 NPC1 (0.40) NPC1RAB9ANSD2TDP1ALDH1A1
SCHEMBL6923029 0.68 IP6K1 (0.41) NPC1RAB9ANSD2TDP1ALDH1A1
SCHEMBL2053729 0.68 IP6K1 (0.41) NPC1RAB9ANSD2TDP1ALDH1A1
SCHEMBL6921974 0.67 POLB (0.45) NPC1RAB9ANSD2TDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075699-A2 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2011-06-23 WO disclosed